These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 15328373)

  • 1. Mad 1 inhibits cell growth and proliferation but does not promote differentiation or overall survival in human U-937 monoblasts.
    Hultquist A; Cetinkaya C; Wu S; Castell A; Erlandsson A; Larsson LG
    Mol Cancer Res; 2004 Aug; 2(8):464-76. PubMed ID: 15328373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the DNA-binding activities of Myc/Max/Mad network complexes during induced differentiation of U-937 monoblasts and F9 teratocarcinoma cells.
    Larsson LG; Bahram F; Burkhardt H; Lüscher B
    Oncogene; 1997 Aug; 15(6):737-48. PubMed ID: 9264414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mad1 expression in the absence of differentiation: effect of cAMP on the B-lymphoid cell line Reh.
    Naderi S; Blomhoff HK
    J Cell Physiol; 1999 Jan; 178(1):76-84. PubMed ID: 9886493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Myc/Max/Mad network members in adipogenesis: inhibition of the proliferative burst and differentiation by ectopically expressed Mad1.
    Pulverer B; Sommer A; McArthur GA; Eisenman RN; Lüscher B
    J Cell Physiol; 2000 Jun; 183(3):399-410. PubMed ID: 10797315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-beta enforces senescence in Myc-transformed hematopoietic tumor cells through induction of Mad1 and repression of Myc activity.
    Wu S; Hultquist A; Hydbring P; Cetinkaya C; Oberg F; Larsson LG
    Exp Cell Res; 2009 Nov; 315(18):3099-111. PubMed ID: 19766114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential expression of the MAD family of transcriptional repressors during differentiation and development.
    Quéva C; Hurlin PJ; Foley KP; Eisenman RN
    Oncogene; 1998 Feb; 16(8):967-77. PubMed ID: 9519870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of mad, mxi1, max and c-myc during induced differentiation of hematopoietic cells: opposite regulation of mad and c-myc.
    Larsson LG; Pettersson M; Oberg F; Nilsson K; Lüscher B
    Oncogene; 1994 Apr; 9(4):1247-52. PubMed ID: 8134128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of TRRAP-dependent hTERT and TRRAP-independent CAD activation by Myc/Max contributes to the differentiation of HL60 cells after exposure to DMSO.
    Jiang G; Bi K; Tang T; Wang J; Zhang Y; Zhang W; Ren H; Bai H; Wang Y
    Int Immunopharmacol; 2006 Jul; 6(7):1204-13. PubMed ID: 16714225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of myc-max-mad gene expression during hepatocyte proliferation in vivo: Differential regulation of mad family and stress-mediated induction of c-myc.
    Mauleon I; Lombard MN; Muñoz-Alonso MJ; Cañelles M; Leon J
    Mol Carcinog; 2004 Feb; 39(2):85-90. PubMed ID: 14750213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
    Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
    Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MAD1 and its life as a MYC antagonist: an update.
    Lüscher B
    Eur J Cell Biol; 2012; 91(6-7):506-14. PubMed ID: 21917351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoic acid-induced growth arrest and differentiation of neuroblastoma cells are counteracted by N-myc and enhanced by max overexpressions.
    Peverali FA; Orioli D; Tonon L; Ciana P; Bunone G; Negri M; Della-Valle G
    Oncogene; 1996 Jan; 12(2):457-62. PubMed ID: 8570225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined IFN-gamma and retinoic acid treatment targets the N-Myc/Max/Mad1 network resulting in repression of N-Myc target genes in MYCN-amplified neuroblastoma cells.
    Cetinkaya C; Hultquist A; Su Y; Wu S; Bahram F; Påhlman S; Guzhova I; Larsson LG
    Mol Cancer Ther; 2007 Oct; 6(10):2634-41. PubMed ID: 17938259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dwarfism and dysregulated proliferation in mice overexpressing the MYC antagonist MAD1.
    Quéva C; McArthur GA; Ramos LS; Eisenman RN
    Cell Growth Differ; 1999 Dec; 10(12):785-96. PubMed ID: 10616903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repression of in vivo growth of Myc/Ras transformed tumor cells by Mad1.
    Cerni C; Skrzypek B; Popov N; Sasgary S; Schmidt G; Larsson LG; Lüscher B; Henriksson M
    Oncogene; 2002 Jan; 21(3):447-59. PubMed ID: 11821957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gamma interferon induces expression of Mad1 gene in macrophage, which inhibits colony-stimulating factor-1-dependent mitogenesis.
    Dey A; Kim L; Li W
    J Cell Biochem; 1999 Feb; 72(2):232-41. PubMed ID: 10022505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mad1 is a transcriptional repressor of Bcl-6.
    Lee SC; Bottaro A; Chen L; Insel RA
    Mol Immunol; 2006 May; 43(12):1965-71. PubMed ID: 16423395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Mad1 protein inhibits proliferation of cancer cells and inversely correlated with Myc protein expression in primary gastric cancer.
    Han S; Park K; Kim HY; Lee MS; Kim HJ; Kim YD
    Oncol Rep; 1999; 6(3):569-74. PubMed ID: 10203593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward the elucidation of the structural determinants responsible for the molecular recognition between Mad1 and Max.
    Montagne M; Naud JF; McDuff FO; Lavigne P
    Biochemistry; 2005 Sep; 44(38):12860-9. PubMed ID: 16171401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression and mutation of myc antagonist genes Mad1, Mxi1 and Rox in leukemia cells].
    Suo XH; Pan L; Yao L; Zhang XJ; Niu ZY; Dong ZR
    Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):745-9. PubMed ID: 18457265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.